Tehran Chemie Pharmaceutical Company (SHTEHRAN) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- SHTEHRAN
- Industry
- Pharmaceuticals
- Market
- IFB Base Market
Latest periods
| Item | To 1405/03/31 | To 1404/03/31 | To 1403/03/31 | To 1402/03/31 | To 1401/03/31 | To 1400/03/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 36,502,025 | 18,506,414 | 13,066,539 | 13,728,391 | 5,171,080 | 2,932,090 |
| Cost of operating revenue | -16,319,075 | -12,408,956 | -9,666,265 | -7,940,800 | -3,500,563 | -2,127,942 |
| Gross profit (loss) | 20,182,950 | 6,097,458 | 3,400,274 | 5,787,591 | 1,670,517 | 804,148 |
| Selling, general and administrative expenses | -1,382,930 | -864,050 | -616,135 | -368,055 | -226,493 | -129,448 |
| Operating profit (loss) | 18,800,020 | 5,233,408 | 2,784,139 | 5,426,678 | 1,478,201 | 673,007 |
| Finance costs | -2,865,235 | -2,851,833 | -2,425,221 | -767,799 | -431,317 | -298,067 |
| Other non-operating income and expenses | 964,964 | 2,769,521 | 1,487,201 | 2,134,866 | 943,714 | 844,187 |
| Profit (loss) from continuing operations before tax | 16,899,749 | 5,151,096 | 1,846,119 | 6,793,745 | 1,990,598 | 1,219,127 |
| Current year tax | -3,212,523 | -478,475 | 0 | -602,307 | -217,576 | -94,214 |
| Net profit (loss) from continuing operations | 13,687,226 | 4,672,621 | 1,846,119 | 6,191,438 | 1,773,022 | 1,124,913 |
| Net profit (loss) | 13,687,226 | 4,672,621 | 1,846,119 | 6,191,438 | 1,773,022 | 1,124,913 |
| Basic earnings (loss) per share | 2,041 rials | 697 rials | 275 rials | 3,971 rials | 3,980 rials | 2,525 rials |
| Net earnings (loss) per share, rials | 2,042 rials | 697 rials | 276 rials | 3,971 rials | 3,980 rials | 2,526 rials |
| Capital | 6,704,775 | 6,704,775 | 6,704,775 | 1,559,250 | 445,500 | 445,500 |
Reporting periods
81 periods are on file for this report, from the period ending 1380/09/30 to the period ending 1405/03/31.